A Case of Intrahepatic Cholangiocarcinoma that Developed 12 Years after Sustained Virological Response was Achieved to Interferon Therapy for Chronic Hepatitis C-Reference-Cited by-同舟云学术

A Case of Intrahepatic Cholangiocarcinoma that Developed 12 Years after Sustained Virological Response was Achieved to Interferon Therapy for Chronic Hepatitis C

Published:2022 Issue:2 Volume:47 Page:174-180
ISSN:0385-7883
Container-title:Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
language:en
Short-container-title:JJCS

Author:

Sano Tomoya¹,Miyashita Seikan¹,Komoda Asuka¹,Kawaguchi Takahito¹,Nishimura Junya¹,Nozawa Akinori¹,Tanaka Hiromu¹,Uenishi Takahiro¹

Affiliation:

1. Department of Surgery, Ishikiriseiki Hospital

Publisher

Japanese College of Surgeons

Subject

Cell Biology,Developmental Biology,Embryology,Anatomy

Link

https://www.jstage.jst.go.jp/article/jjcs/47/2/47_174/_pdf

Reference25 articles.

1. 1) Yoshida Y, Yonezawa M, Okamoto T, et al:Occurrence of hepatocellular carcinoma 24 years after successful interferon therapy in a patient with chronic hepatitis C: a case report. Clin J Gastroenterol 12:120-127, 2019

2. 2) 日本肝癌研究会追跡調査委員会編：第20回全国原発性肝癌追跡調査報告（2008～2009）．肝臓 60：258-293，2019

3. 3) George PM, Badiger R, Alazawi W, et al:Pharmacology and therapeutic potential of interferons. Pharmacol Ther 135:44-53, 2012

4. 4) Asahina Y, Tsuchiya K, Nishimura T, et al:Alpha-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C. Hepatology 58:1253-1262, 2013

5. 5) Cardoso AC, Moucari R, Figueiredo-Mendes C, et al:Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma:incidence and survival in hepatitis C patients with advanced fibrosis. J Hepatol 52:652-657, 2010